Advertisement
Screener

Vincerx Pharma, Inc. General and Administrative Expense

Vincerx Pharma, Inc. General and Administrative Expense

Vincerx Pharma, Inc. reported General and Administrative Expense of $2.32 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:GeneralAndAdministrativeExpense · last filed 2025-05-15

  • Vincerx Pharma, Inc. general and administrative expense for the quarter ending 2025-03-31 was $2.32M, a 20.74% decline year-over-year.
  • Vincerx Pharma, Inc. general and administrative expense for the quarter ending 2024-12-31 was $5.56M, a 205.38% increase year-over-year.
  • Vincerx Pharma, Inc. general and administrative expense for the quarter ending 2024-09-30 was $3.88M, a 10.75% increase year-over-year.
  • Vincerx Pharma, Inc. general and administrative expense for the quarter ending 2024-06-30 was $3.61M, a 5.22% decline year-over-year.
  • Vincerx Pharma, Inc. general and administrative expense for fiscal 2024 was $15.98M, a 17.17% increase from fiscal 2023.
  • Vincerx Pharma, Inc. general and administrative expense for fiscal 2023 was $13.64M, a 27.79% decline from fiscal 2022.
  • Vincerx Pharma, Inc. general and administrative expense for fiscal 2022 was $18.89M, a 16.35% decline from fiscal 2021.
  • Vincerx Pharma, Inc. general and administrative expense for fiscal 2021 was $22.57M, a 527.43% increase from fiscal 2020.
Period endGeneral and Administrative Expense 3 monthGeneral and Administrative Expense 3 month as first filedGeneral and Administrative Expense 6 monthGeneral and Administrative Expense 6 month as first filedGeneral and Administrative Expense 9 monthGeneral and Administrative Expense 10 monthGeneral and Administrative Expense 12 monthGeneral and Administrative Expense 12 month as first filed
2025-03-31$2.32M
10-Q · filed 2025-05-15
$7.87M
derived: sum of 2 quarters · filed 2025-05-15
$11.76M
derived: sum of 3 quarters · filed 2025-05-15
$15.37M
derived: sum of 4 quarters · filed 2025-05-15
2024-12-31$5.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$9.44M
derived: sum of 2 quarters · filed 2025-03-27
$13.05M
derived: sum of 3 quarters · filed 2025-03-27
$15.98M
10-K · filed 2025-03-27
2024-09-30$3.88M
10-Q · filed 2024-11-12
$7.50M
derived: sum of 2 quarters · filed 2024-11-12
$10.42M
10-Q · filed 2024-11-12
$12.24M
derived: sum of 4 quarters · filed 2025-05-15
2024-06-30$3.61M
10-Q · filed 2024-08-08
$6.53M
10-Q · filed 2024-08-08
$8.35M
derived: sum of 3 quarters · filed 2025-05-15
$11.86M
derived: sum of 4 quarters · filed 2025-05-15
2024-03-31$2.92M
10-Q · filed 2025-05-15
$4.74M
derived: sum of 2 quarters · filed 2025-05-15
$8.25M
derived: sum of 3 quarters · filed 2025-05-15
$12.06M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31$1.82M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
$5.33M
derived: sum of 2 quarters · filed 2025-03-27
$9.14M
derived: sum of 3 quarters · filed 2025-03-27
$13.64M
10-K · filed 2025-03-27
2023-09-30$3.51M
10-Q · filed 2024-11-12
$3.52M
10-Q · filed 2023-11-14
$7.32M
derived: sum of 2 quarters · filed 2024-11-12
$11.82M
10-Q · filed 2024-11-12
$15.80M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30$3.81M
10-Q · filed 2024-08-08
$3.79M
10-Q · filed 2023-08-07
$8.31M
10-Q · filed 2024-08-08
$8.30M
10-Q · filed 2023-08-07
$12.29M
derived: sum of 3 quarters · filed 2024-08-08
$16.82M
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31$4.50M
10-Q · filed 2024-05-14
$4.51M
10-Q · filed 2023-05-11
$8.48M
derived: sum of 2 quarters · filed 2024-05-14
$13.00M
derived: sum of 3 quarters · filed 2024-05-14
$17.73M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$3.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$8.51M
derived: sum of 2 quarters · filed 2024-03-29
$13.23M
derived: sum of 3 quarters · filed 2024-03-29
$18.89M
10-K · filed 2024-03-29
$18.95M
10-K · filed 2023-03-28
2022-09-30$4.53M
10-Q · filed 2023-11-14
$9.25M
derived: sum of 2 quarters · filed 2023-11-14
$14.90M
10-Q · filed 2023-11-14
$20.27M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30$4.72M
10-Q · filed 2023-08-07
$10.38M
10-Q · filed 2023-08-07
$15.75M
derived: sum of 3 quarters · filed 2023-08-07
$21.47M
derived: sum of 4 quarters · filed 2023-08-07
2022-03-31$5.66M
10-Q · filed 2023-05-11
$11.03M
derived: sum of 2 quarters · filed 2023-05-11
$16.75M
derived: sum of 3 quarters · filed 2023-05-11
$23.44M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$5.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28
$11.09M
derived: sum of 2 quarters · filed 2023-03-28
$17.78M
derived: sum of 3 quarters · filed 2023-03-28
$22.57M
10-K · filed 2023-03-28
2021-09-30$5.72M
10-Q · filed 2022-11-10
$12.41M
derived: sum of 2 quarters · filed 2022-11-10
$17.21M
10-Q · filed 2022-11-10
$20.46M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$6.70M
10-Q · filed 2022-08-11
$11.49M
10-Q · filed 2022-08-11
$14.74M
derived: sum of 3 quarters · filed 2022-08-11
$15.05M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$4.79M
10-Q · filed 2022-05-12
$8.05M
derived: sum of 2 quarters · filed 2022-05-12
$8.35M
derived: sum of 3 quarters · filed 2022-05-12
$8.38M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$3.26M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$3.56M
derived: sum of 2 quarters · filed 2022-03-29
$3.59M
derived: sum of 3 quarters · filed 2022-03-29
$3.60M
10-K · filed 2022-03-29
2020-09-30$305.00K
10-Q · filed 2021-11-12
$338.00K
derived: sum of 2 quarters · filed 2021-11-12
$342.00K
10-Q · filed 2021-11-12
2020-06-30$33.00K
10-Q · filed 2021-08-12
$37.00K
10-Q · filed 2021-08-12
2020-03-31$4.00K
10-Q · filed 2021-05-17
2019-12-31$45.00K
10-K/A · filed 2021-05-14